Research location
Hamar
Norway
Advertisement
Research activity in Hamar
NorwayCureCurrent currently publishes aggregate city-level research activity for this location: 67 trials and 70 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Hamar
67 linked trials · page 1 of 2Management of Patients With Heart Failure at Home After Hospital DischargeNCT06576752 · 2024-10-01 · 1 site observation
RECRUITING
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate CancerNCT05448547 · 2022-11-04 · 1 site observation
RECRUITING
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyNCT06797869 · 2025-01-29 · 1 site observation
COMPLETED
A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)NCT05646706 · 2023-01-04 · 1 site observation
COMPLETED
A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecNCT05352815 · 2022-06-01 · 1 site observation
COMPLETED
A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.NCT04661917 · 2021-05-31 · 2 site observations
WITHDRAWN
A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic PainNCT04641273 · 2021-01-22 · 1 site observation
TERMINATED
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or ObesityNCT03574597 · 2018-10-24 · 1 site observation
COMPLETED
Effect of Efpeglenatide on Cardiovascular OutcomesNCT03496298 · 2018-04-27 · 1 site observation
TERMINATED
A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene MutationNCT03439514 · 2018-04-17 · 1 site observation
TERMINATED
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskNCT03315143 · 2017-12-19 · 1 site observation
TERMINATED
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes MellitusNCT03086330 · 2017-03-15 · 1 site observation
COMPLETED
A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic DrugsNCT03078478 · 2017-03-13 · 1 site observation
COMPLETED
The Norwegian Drug Monitoring StudyNCT03074656 · 2017-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Oral Semaglutide Using a Flexible Dose Adjustment Based on Clinical Evaluation Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus.NCT02849080 · 2016-09-20 · 1 site observation
COMPLETED
A Prospective Evaluation of Natriuretic Peptide Based Referral of CHF Patients in Primary CareNCT02807857 · 2016-07-07 · 1 site observation
COMPLETED
A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes MellitusNCT02501161 · 2016-01-31 · 1 site observation
COMPLETED
Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)NCT02580591 · 2015-12-22 · 1 site observation
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney DiseaseNCT02540993 · 2015-09-17 · 2 site observations
COMPLETED
Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney DiseaseNCT02545049 · 2015-09-17 · 2 site observations
COMPLETED
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)NCT02414958 · 2015-06-30 · 1 site observation
COMPLETED
Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary DiseaseNCT02419872 · 2015-05-31 · 1 site observation
COMPLETED
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.NCT02296138 · 2015-01-13 · 1 site observation
COMPLETED
Effectiveness of "Medisinstart"NCT02261402 · 2014-10-01 · 1 site observation
COMPLETED
The NOR-SWITCH StudyNCT02148640 · 2014-10-01 · 1 site observation
COMPLETED
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT02236611 · 2014-09-26 · 1 site observation
COMPLETED
The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on TiotropiumNCT01899742 · 2014-09-15 · 1 site observation
COMPLETED
Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 DiabetesNCT01930188 · 2013-12-02 · 1 site observation
COMPLETED
The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 DiabetesNCT01836523 · 2013-11-01 · 1 site observation
COMPLETED
Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)NCT02006732 · 2013-11-01 · 1 site observation
COMPLETED
SER100 in Isolated Systolic HypertensionNCT01987284 · 2013-10-01 · 1 site observation
COMPLETED
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy RegistryNCT01892319 · 2013-09-30 · 1 site observation
COMPLETED
A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol With Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT01879410 · 2013-06-13 · 1 site observation
COMPLETED
Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic NephropathyNCT01874431 · 2013-06-12 · 1 site observation
COMPLETED
A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime InsulinNCT01713530 · 2013-02-21 · 1 site observation
COMPLETED
Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple SclerosisNCT01457924 · 2011-11-01 · 1 site observation
COMPLETED
Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and MetforminNCT01388361 · 2011-09-01 · 1 site observation
COMPLETED
12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes MellitusNCT01370005 · 2011-06-01 · 1 site observation
COMPLETED
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 DiabetesNCT01243424 · 2010-11-11 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine in Type 1 DiabetesNCT01079234 · 2010-03-01 · 1 site observation
COMPLETED
CANVAS - CANagliflozin cardioVascular Assessment StudyNCT01032629 · 2009-12-09 · 1 site observation
COMPLETED
Comparison of NN1250 With Insulin Glargine in Type 2 DiabetesNCT01006291 · 2009-11-01 · 1 site observation
COMPLETED
Saxagliptin Compared to Glimepiride in Elderly Type 2 Diabetes Patients, With Inadequate Glycemic Control on MetforminNCT01006603 · 2009-10-01 · 1 site observation
COMPLETED
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesNCT00982644 · 2009-09-01 · 1 site observation
COMPLETED
Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 DiabetesNCT00954447 · 2009-08-01 · 1 site observation
COMPLETED
European Study of Cardiovascular RiskNCT00882336 · 2009-05-01 · 1 site observation
COMPLETED
Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label ExtensionNCT00881530 · 2009-03-01 · 1 site observation
COMPLETED
BI 10773 add-on to Metformin in Patients With Type 2 DiabetesNCT00749190 · 2008-08-01 · 1 site observation
COMPLETED
18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)NCT00666458 · 2008-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 DiabetesNCT00622284 · 2008-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.